關於我們
At the HKBU and IncreasePharm Joint Centre for Nucleic Acid Drug Discovery (NADD), we specialize in utilizing cutting-edge information technology to accelerate the discovery and development of nucleic acid-based drugs. Our location in Hong Kong allows us to collaborate with top researchers and pharmaceutical companies in the region to drive innovation in this field.
Innovating Nucleic Acid Therapeutics
Innovating Nucleic Acid Therapeutics
As the demand for more effective and efficient treatments continues to grow, the field of drug discovery has become increasingly complex and challenging. At the HKBU and IncreasePharm Joint Centre for Nucleic Acid Drug Discovery .NADD., we specialize in utilizing cutting-edge technologies and innovative approaches to accelerate the discovery and development of nucleic acid-based drugs. Our team of experts brings together a unique combination of expertise in both nucleic acid research and drug discovery, making us a leader in this field.
The HKBU and IncreasePharm Joint Centre for Nucleic Acid Drug Discovery .NADD. is a unique collaboration between Hong Kong Baptist University .HKBU. and IncreasePharm, focused on the development of innovative nucleic acid-based drugs. Our approach combines the expertise of HKBU in nucleic acid research with the drug discovery capabilities of IncreasePharm, creating a powerful synergy that has the potential to revolutionize the field of drug discovery.